Cornell researchers developed an imaging tool to create intricate spatial maps of the locations and identities of hundreds of different microbial species, such as those that make up the gut microbiome.
A Cornell-led collaboration has developed a noninvasive blood test that uses cell-free DNA to gauge the damage that COVID-19 inflicts on cells, tissues and organs, and could help aid in the development of new therapies.
Serving residents of two upstate New York counties, the HOPES program led by Rana Zadeh is providing secure medication organizers and training to help prevent potentially dangerous and costly mishaps.
The university launched its COVID-19 testing program for students July 16 as part of a multipronged public health effort. The initial focus is “arrival testing,” in which students are tested upon their return to the Ithaca area.
A new study of planaria, a type of flatworm, shows how stem cells are able to postpone their own death in order to respond to an injury that needs their attention.
A new study has uncovered key details for how the Salmonella bacteria that causes typhoid fever identifies a host’s immune cells and delivers toxins that disrupt the immune system and allow the pathogen to spread.
Jeff Niederdeppe, associate professor of communication at Cornell University, studies the mechanisms and effects of mass media campaigns, strategic health messages and news coverage in shaping health behavior. He says the potential restrictions highlight how flavored e-cigarettes are directly targeted toward young people.
A new Android app developed by Cornell Tech researchers and collaborators will make it easy for people to collect their personal health data and share it with trusted medical providers or apps.
Many Americans remain confused about when COVID-19 vaccines provide strong protection and the need for continued public health precautions, according to new Cornell research.
